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NMR Biomntravoxel water diffusion heterogeneity imaging for brain tumor
characterization and evaluation of high-grade gliomas, by comparing an established heterogeneity index (a value)
measured in human high-grade gliomas to those of normal appearing white and grey matter landmarks. Twenty
patients with high-grade gliomas prospectively underwent diffusion-weighted magnetic resonance imaging using
multiple b-values. The stretched-exponential model was used to generate a and distributed diffusion coefficient
(DDC) maps. The a values and DDCs of the tumor and contralateral anatomic landmarks were measured in each
patient. Differences between a values of tumors and landmark tissues were assessed using paired t-tests. Correlation
between tumor a and tumor DDC was assessed using Pearson’s correlation coefficient. Mean a of tumors was
significantly lower than that of contralateral frontal white matter (p¼ 0.0249), basal ganglia (p< 0.0001), cortical
grey matter (p< 0.0001), and centrum semiovale (p¼ 0.0497). Correlation between tumor a and tumor DDC was
strongly negative (Pearson correlation coefficient, S0.8493; p< 0.0001). The heterogeneity index a of human
high-grade gliomas is significantly different from those of normal brain structures, which potentially offers a new
method for evaluating brain tumors. The observed negative correlation between tumor a and tumor DDC requires
further investigation. Copyright  2009 John Wiley & Sons, Ltd.
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The incidence of gliomas is around five to ten per 100 000 in the
general population (1,2). High-grade [World Health Organization
(WHO) grade III and IV] astrocytomas are the most common
gliomas, with glioblastomas being about four times more
common than anaplastic astrocytomas (1,2). Despite decades
of intensive clinical and laboratory research, high-grade gliomas
are still considered incurable, with a poor median survival (1 year
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ciently specific, final diagnosis and tumor grade still have to be
established by histopathological examination of tumor biopsy
samples or by surgical resection (1,2). More accurate preoperative
grading of primary brain tumors could increase the diagnostic
yield of brain biopsies, thereby improving patient management.
Another contributing factor to the poor survival of patients with
high-grade gliomas is the inability of currently available imaging
techniques to accurately delineate the tumor, as a result of which
targeted focal treatments may not be effective (3). In addition,e M. K. Ivancevic
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conventional imaging is not able to give an early assessment of
the effectiveness of radiation and/or chemotherapy (3). Another
unsolved issue is the distinction between radiation-induced
necrosis from tumor recurrence (3). Early identification of patients
with a poor treatment response or who suffer from tumor
recurrence can be of great advantage: it provides the opportunity
to adjust individual treatment regimes more rapidly, and sparing
patients unnecessary morbidity, expense and delay in initiation
of effective treatment. The application of diffusion-weighted
magnetic resonance (MR) imaging (DWI) for brain tumor
characterization and evaluation of gliomas is under active
investigation (3–5). Evidence regarding the effectiveness of DWI
regarding brain tumor characterization, tumor delineation, and
differentiation between radiation-induced necrosis and tumor
recurrence is either conflicting or scarce (3), while a voxel-based
quantitative DWI approach [functional diffusion mapping,
currently referred to as parametric response mapping of diffusion
(PRMADC)] has recently shown promise of giving an early
prediction of survival in patients with high-grade gliomas (4,5).
Diffusion in biological tissue is most frequently quantified
using a mono-exponential model. However, diffusion-weighted
signal decay in the brain and in brain tumors has been shown to
be multi-exponential (6), and the bi-exponential model may be a
better way to describe the admixture of multiple exponential
signal decays (6). However, the bi-exponential model is probably
also an oversimplification of reality, and it is more realistic to
assume a larger number (> 2) of intravoxel proton pools with
different diffusion coefficients (7). Moreover, detailed studies of
animal and human brain tissue have determined that assump-
tions of fast and slow compartments being extra- and
intracellular water pools, respectively, are not supported by
empirical data (8).
To overcome the difficulty of making assumptions about the
number of intravoxel proton pools with different diffusion
coefficients in biological tissue, Bennett et al. (7,9,10) introduced
the stretched-exponential model. The stretched-exponential
model is described as follows:
SðbÞ=So ¼ expððb DDCÞaÞ; (1)
where S(b) is the signal magnitude with diffusion weighting b, S0
is the signal magnitude with no diffusion weighting, b is the
b-value, the index a relates to intravoxel water diffusion
heterogeneity, varying between 0 and 1, and the DDC is the
distributed diffusion coefficient, representing mean intravoxel
diffusion rates. Interestingly, this model introduces a new
parameter (a), which provides a new type of image contrast
(different from conventional DWI), that relates to the degree of
intravoxel water diffusion heterogeneity. By inspection of
equation (1), it should be clear an a¼ 1 is equivalent to
mono-exponential diffusion-weighted signal decay, thus low
intravoxel diffusion heterogeneity. Conversely an a near 0
indicates a higher degree of multi-exponential signal decay
(7,9,10). This convention maintains consistency with Bennett and
colleagues’ (7,9,10) definition of a as a heterogeneity index,
although we remind the reader that a numerically high a
index (i.e. a approaching 1) represents low intravoxel diffusion
heterogeneity approaching mono-exponential decay, and a
numerically low a index (i.e. a approaching 0) represents a high
degree of diffusion heterogeneity exhibited as multi-exponential
decay. Another key point worth emphasis is that the term
‘heterogeneity’ in this context refers to intravoxel heterogeneity ofwww.interscience.wiley.com/journal/nbm Copyright  200exponential decay, as opposed to intervoxel heterogeneity of
diffusion coefficients as often is the case particularly in tumor.
After fitting the stretched-exponential model to the acquired DWI
data, pixel-by-pixel a and DDC maps can be obtained, allowing
for visual and (regional) quantitative evaluation of a values and
DDCs, respectively (7,9,10).
So far, the stretched-exponential model has only been
investigated in animal models and healthy volunteers (7,9,10).
Since high-grade gliomas are histologically more heterogeneous
than normal brain tissue (1,2,11), we hypothesized that a values
in high-grade gliomas are lower than those in normal brain
structures. The purpose of this study was therefore to determine
the potential diagnostic value of intravoxel heterogeneity
imaging for brain tumor characterization and evaluation of
high-grade gliomas, by comparing a values of human high-grade
gliomas to those of anatomic landmarks.MATERIALS AND METHODS
Patients
This study was approved by the local institutional review board
and written informed consent was obtained from all participants.
Twenty patients with high-grade glioma [ten men, ten women,
mean age 58.2 years (range, 20–89 years), WHO grade III: n¼ 3,
WHO grade IV: n¼ 17, mean tumor volume 23.4ml (range
0.4–88.6ml), temporal lobe as primary tumor location: n¼ 11,
frontal lobe as primary tumor location: n¼ 4, occipital lobe as
primary tumor location: n¼ 3, parietal lobe as primary tumor
location: n¼ 2] prospectively underwent DWI of the brain, before
any treatment was started. Exclusion criteria were general
contraindications to MR imaging, such as implanted pacemaker
and claustrophobia.
MR imaging
All patients were examined with a 3.0 T MR scanner (Achieva 3.0 T
Quasar Dual, Philips Healthcare, Best, The Netherlands) using a
eight-channel head coil. DWI was performed using a single-shot
(SS) spin-echo (SE) echo-planar imaging (EPI) sequence, with the
following parameters: repetition time/echo time of 8700/60ms,
image acquisiton in the axial plane, slice thickness/gap of 4/
1mm, number of slices of 28, field of view of 240 240mm,
acquisition matrix of 128 99, motion probing gradients (MPGs)
in three orthogonal axes, b-values of 0, 1000, 2000, and 4000 s/
mm2, number of signal averages of 1 (for b-value of 0 s/mm2), 2
(for b-value of 1000 s/mm2), and 3 (for b-values of 2000 and
4000 s/mm2), phase encode reduction of 77.8%, half scan factor
of 0.733, parallel imaging (SENSitivity Encoding [SENSE]) factor of
3, EPI factor of 35, spectral presaturation inversion recovery (SPIR)
fat suppression, actual voxel size of 1.88 2.41 4.00mm3,
reconstructed voxel size of 0.94 0.94 4.00mm3, and total scan
time of 4min and 30 s. In all patients, routine anatomical pre- and
post- post-gadolinium 3D T1-weighted fast field echo, turbo SE
axial T2-weighted, and turbo SE axial fluid-attenuated inversion
recovery (FLAIR) sequences were performed in addition to axial
DWI sequences.
Image analysis
The stretched-exponential model [equation (1)] was fitted to the
obtained DWI data using a nonlinear least-squares routine, to9 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 179–187
Figure 1. Scatter plot with mean tumor a (x-axis) vs. mean tumor DDC
(y-axis) including the dashed regression line. Error bars represent SD of
each tumor VOI.
DIFFUSION HETEROGENEITY IMAGING OF HIGH-GRADE GLIOMAScreate whole-brain isotropic a and DDC maps (7,9,10). Noise
thresholds were set to restrict diffusion calculation to only pixels
safely above background noise to avoid fitting voxels with low
signal-to-noise ratio (SNR). Freehand volumes of interest (VOIs)
were placed in the tumor and in four contralateral anatomic
landmarks (frontal white matter, basal ganglia (putamen and
head of caudate nucleus), cortical grey matter, and centrum
semiovale) in each patient by one of the authors (T.C.K.). Tumor
VOIs were contoured on post-gadolinium T1-weighted images.
If a cystic (resection) cavity was present, it was included within
the tumor VOI if circumscribed by contrast enhancement
and excluded if outside the enhancing region. Furthermore, all
regions with an impeded diffusion relative to the surrounding
brain parenchyma were included in the tumor VOIs. All other
MR sequences were used to identify (apparently) unaffected
contralateral anatomic landmarks. Care was taken to avoid
inclusion of parts of the ventricles and subarachnoid cisterns into
the VOIs, in order to minimize partial volume averaging effects
between tumor/anatomic landmarks and the relatively fast-
diffusing cerebrospinal fluid (7). When identifying tumor and
anatomic landmarks and creating corresponding VOIs, the
observer was blinded to a and DDC maps. Subsequently, defined
VOIs were applied to a and DDC maps, and a values and DDCs of
tumor and anatomic landmarks were automatically calculated. All
image processing and analysis was performed on in-house
software developed in Matlab (The Mathworks, Inc., Natick, MA).
Statistical analysis
Differences between a values of tumors and a values of
contralateral anatomic landmarks, and differences between DDCs
of tumors and DDCs of contralateral anatomic landmarks were
assessed using paired t tests. Due to findings by Bennett et al. (9),
which showed in an animal model of glioma that intrasubject
variability in the a value was higher in tumor and peritumor VOIs
than in either grey or white matter, differences between standard
deviations (SDs) of a values of tumors and contralateral anatomic
landmarks were also assessed using paired t-tests. Correlation
between tumor a and tumor DDC was assessed using Pearson’s
correlation coefficient. P-values< 0.05 were considered statisti-
cally significant. Statistical analyses were executed using MedCalc
Software (MedCalc, Mariakerke, Belgium).RESULTS
All measurements could be performed, except for the frontal
white matter contralateral to the tumor in one patient, which was
affected by edema. Results are displayed in Table 1. Mean a of
tumors was significantly lower than mean a of contralateralTable 1. Mean SD a values and DDCs (in 103mm2/s) of
different brain structures and tumor
Tissue a DDC
Frontal white matter 0.62 0.01 0.80 0.09
Basal ganglia 0.80 0.03 0.64 0.05
Cortical grey matter 0.72 0.03 0.72 0.04
Centrum semiovale 0.62 0.02 0.70 0.05
Tumor 0.58 0.08 1.64 0.71
NMR Biomed. 2010; 23: 179–187 Copyright  2009 John Wileyfrontal white matter (p¼ 0.0249), basal ganglia (p< 0.0001),
cortical grey matter (p< 0.0001), and centrum semiovale
(p¼ 0.0497). Mean DDC of tumors was significantly higher than
mean DDC of contralateral frontal white matter (p¼ 0.0001),
basal ganglia (p< 0.0001), cortical grey matter (p< 0.0001), and
centrum semiovale (p< 0.0001). Mean SD of a values of tumors
was significantly higher than mean SD of a values of contralateral
frontal white matter (p< 0.0001), basal ganglia (p< 0.0001),
cortical grey matter (p¼ 0.0123), and centrum semiovale
(p< 0.0001). The correlation between tumor a and tumor
DDC, which was strongly negative (Pearson correlation coeffi-
cient, 0.8493; P< 0.0001) is presented in Figure 1. Figures 2–5
present representative examples of a and DDC maps of
high-grade gliomas. Examples of the stretched-exponential
model fit to target tissues (white matter, grey matter, basal
ganglia, and tumor) are illustrated in Figure 6.1
DISCUSSION
In this study, we found that a values of human high-grade
gliomas were significantly lower than those of (apparent) normal
brain structures. This finding can be explained by the fact that
high-grade gliomas, in particular glioblastoma multiforme (85%
of included patients), are associated with considerable histo-
logical heterogeneity (1,2,11); the high degree of cellular
pleomorphism (i.e. high variability in the size and shape of cells
and cellular nuclei), the presence of intravoxel microscopic cystic/
necrotic foci, and intravoxel heterogeneity in vascular structures
may lead to the existence of a high number of different
compartments with different proton pools (i.e. lower a values) in
high-grade gliomas, relative to normal, unaffected brain tissue.
This hypothesis is further supported by the fact that SD of a
values of high-grade gliomas was significantly higher than that of
contralateral anatomic landmarks, which reflects their variable
histological heterogeneity; similar results were reported in an
animal model of glioma (9). Furthermore, in the present study& Sons, Ltd. www.interscience.wiley.com/journal/nbm
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Figure 2. A 28-year-old male with a high-grade glioma (WHO grade III) in the left temporal lobe. Axial post-gadolinium T1-weighted image with tumor
VOI (a), diffusion-weighted images at b-values of 0 s/mm2 (b), 1000 s/mm2 (c), 2000 s/mm2 (d), and 4000 s/mm2 (e), and isotropic ADC (f ), DDC (g), and a
(h) maps show the tumor (arrow). This tumor had a mean DDC of 1.01 103mm2/s and a mean a value of 0.55. Note the good contrast between the
tumor and the surrounding brain tissue on the a map (H).
Figure 3. A 46-year-old male with a high-grade glioma (WHO grade IV) in the right frontal lobe. Axial post-gadolinium T1-weighted image with tumor
VOI (a), diffusion-weighted images at b-values of 0 s/mm2 (b), 1000 s/mm2 (c), 2000 s/mm2 (d), and 4000 s/mm2 (e), and isotropic ADC (f ), DDC (g), and a
(h) maps show the tumor (arrow). This tumor had a mean DDC of 2.66 103mm2/s and a mean a value of 0.53. Note the good contrast between the
tumor and the surrounding brain tissue on the a map (H).
www.interscience.wiley.com/journal/nbm Copyright  2009 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 179–187




Figure 4. A 61-year-old male with a high-grade glioma (WHO grade IV) in the right parietal lobe. Axial post-gadolinium T1-weighted image with tumor
VOI (a), diffusion-weighted images at b-values of 0 s/mm2 (b), 1000 s/mm2 (c), 2000 s/mm2 (d), and 4000 s/mm2 (e), and isotropic ADC (f ), DDC (g), and a
(h) maps show the tumor (arrow). This tumor had a mean DDC of 0.68 103mm2/s and a mean a value of 0.65. In this case, overall contrast between the
tumor and surrounding brain tissue was moderate on the amap (H). Nevertheless, the center of the tumor clearly exhibited a lower a value (arrowhead).
Figure 5. A 51-year-old female with a high-grade glioma (WHO grade IV) in the left occipital lobe. Axial post-gadolinium T1-weighted image with tumor
VOI (a), diffusion-weighted images at b-values of 0 s/mm2 (b), 1000 s/mm2 (c), 2000 s/mm2 (d), and 4000 s/mm2 (e), and isotropic ADC (f ), DDC (g), and a
(h) maps show the tumor (arrow). This tumor had a mean DDC of 0.77 03mm2/s and a mean a value of 0.70. In this case, overall contrast between the
tumor and surrounding brain tissue was poor on the amap (H); mean a values of the frontal white matter (0.61) and of the white matter in the centrum
semiovale (0.65) were even lower than that of the tumor (0.70).
NMR Biomed. 2010; 23: 179–187 Copyright  2009 John Wiley & Sons, Ltd. www.interscience.wiley.com/journal/nbm
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tumor a and tumor DDC were strongly negatively correlated
(Fig. 1). It is well known that there is an inverse correlation
between tumor cellularity and tumor diffusion coefficient (3).
Combining these observations may suggest that a values of
cystic or necrotic tumors are lower than those of highly cellular
tumors. However, it should be noted that in the present study we
selected more solid elements of the tumor by defining VOIs
based on contrast enhancement. Cystic cavities were only
included in the tumor VOI if circumscribed by contrast
enhancement and excluded if outside the enhancing region.
In addition, high water mobility environments, such as cystic or
necrotic components of tumor, typically did not retain sufficient
SNR at b¼ 4000 s/mm2 to be reliably fit by the stretche-
d-exponential model. As described previously, a SNR-threshold
filter was applied prior to model fitting to tag low SNR voxels as
‘not-a-number’ thus removing them from subsequent analysis.
Thus, the observed negative correlation between the a value and
DDC does not necessarily apply to the pure cystic/necrotic
portions of the tumor. Furthermore, a drawback of the VOI-based
averaging is the loss of macroscopic heterogeneity of local tissue
in parameters (a and DDC in this case). Therefore, despite our
focus on more solid elements of the tumor, we would like to note
there remains substantial macroscopic heterogeneity in tumor
over individual VOIs as is well illustrated by the (wide range of )
SDs of a and DDC values in Figure 1. Thus, further research is
necessary to clarify the observed negative correlation between
tumor a and tumor diffusion coefficient.
An important issue in the management of brain tumors is the
selection of the most suitable biopsy target for accurate
histopathological diagnosis (1–3). Since tumor grade is assigned
on the basis of the region of highest grade anywhere in the
tumor, an imaging test that could reliably depict such a site of
highest tumor grade would be optimal for increasing the
likelihood of correct diagnosis (1–3). Currently, selection of the
biopsy target is usually based on the lesion’s anatomic
appearance and its contrast enhancement properties; biopsy is
typically performed in an area of strong contrast enhancement.
Interestingly, it is well-known that WHO grade is correlated to the
degree of histological heterogeneity (1,2,11). Since degree of
histological heterogeneity may be well correlated to intravoxel
diffusion heterogeneity, a maps may not only be useful for
preoperative grading of brain tumors, but also for identifying
the site of highest tumor grade for biopsy. This may increase the
diagnostic yield of brain biopsies, which, in turn, may improve
treatment planning and determining prognosis. On the other
hand, the differences in a values between tumor and white
matter was relatively small, and sensitivity of intravoxel diffusion
heterogeneity for characterization of tumor grade may be ofFigure 6. Examples of the stretched-exponential model fit to target
tissues in a 46-year-old male with a high-grade glioma (WHO grade
IV) in the right frontal lobe (same patient as in Fig. 2). Axial isotropic a
maps with regions of interest (ROIs) in the frontal white matter (a), basal
ganglia (c), cortical greymatter (e), white matter in the centrum semiovale
(g), and tumor (i), and corresponding graphs with b-value (x-axis) against
logarithm of relative signal intensity (y-axis) for each ROI (b, d, f, h, j). The
mean a value of the tumor ROI (0.57) was lower than those of the ROIs in
the frontal white matter (0.74), basal ganglia (0.67), cortical grey matter
(0.75), and white matter in the centrum semiovale (0.68). The more
non-mono-exponential decay of the tumor relative to the other brain
structures is well visualized by the degree of deviation from a straight line
in the graph with b-value against logarithm of relative signal intensity (H).
9 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 179–187
Figure 7. A 28-year-old male with a high-grade glioma (WHO grade III) in the left temporal lobe (same patient as in Fig. 2). Axial post-gadolinium
T1-weighted image with tumor VOI (a), diffusion-weighted images at b-values of 0 s/mm2 (b), 1000 s/mm2 (c), 2000 s/mm2 (d), and 4000 s/mm2 (e), and
isotropic ADC (f ), DDC (g), and a (h) maps show the tumor (arrow). There is no evident contrast enhancement in the corpus callosum on the
post-gadolinium image (arrowhead) (A). On the a map, however, a low a value can be seen in the corpus callosum (arrowhead) (H), suggesting tumor
extension to the contralateral side of the brain.
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concern (Figs. 4 and 5). Therefore, future animal/human studies
with histopathological correlation are needed to confirm this
theory.
Accurate local staging of the tumor is a requisite for
appropriate locoregional therapy planning, including radio-
therapy, chemotherapy, and surgery (1,2). In particular, it is
important to correctly exclude or confirm tumor involvement in
the unenhancing region of peritumoral edema, but this is still an
unsolved diagnostic problem (3). Furthermore, although high-
grade gliomas rarely metastasize extracranially, it is well known
that microscopic tumor spread at a considerable distance from
the primary location may occur, which often remains undetected
using conventional imaging (12,13). Bennett et al. (9) showed in
an animal study that a values of peritumoral brain tissue were
significantly lower than in the normal white matter. Fluorescence
microscopy confirmed the presence of tumor cells in the peritumor
region that could be histologically distinguished from the main
tumor mass. Furthermore, there was no change on proton
density or T2-weighted images in the peritumor region, making
vasogenic edema, gliosis, or subacute peritumoral infarction
unlikely as sources of contrast (9). However, in the present study,
determining whether intravoxel diffusion heterogeneity imaging
can diagnose tumor involvement in the unenhancing region of
peritumoral edema would remain speculative because of the
absence of histopathological correlation (3). Nevertheless, we
incidentally observed findings that may support the use of
intravoxel diffusion heterogeneity imaging in the assessment of
tumor extent. For example, in one case the a index map
suggested involvement of the corpus callosum and tumor
extension to the contralateral side of the brain, despite theNMR Biomed. 2010; 23: 179–187 Copyright  2009 John Wileyabsence of contrast enhancement (Fig. 7). Other MR sequences
supported this finding.
Currently, response to therapy in glioma patients is assessed
using the MacDonald criteria, which are based on uni- or bi-
dimensional changes in tumor size on enhanced MR imaging
(14). Although volumetric tumor measurements have been
reported to be more predictive of survival in recurrent glioma
than uni- and bi-dimensional tumor measurements (15), tumor
size measurements in general do not allow individualizing
treatment, because the measurements are made well after the
completion of therapy. Recently, a voxel-based quantitative DWI
approach was introduced (PRMADC), which allows visualization
and calculation of tumor diffusion coefficient changes during
treatment and takes into account spatial heterogeneity of tumor
response (unlike mean diffusion coefficient measurements) (4,5).
PRMADC combined with traditional radiological response criteria
proved to provide a significantly better prediction of response
to therapy than traditional radiological criteria or functional
diffusion mapping alone (4,5). Possibly, a of the tumor may
also change during treatment (due to changes in histological
heterogeneity). Further research is required to investigate this
possible application.
Conventional imaging is often unreliable in distinguishing
radiation necrosis from recurrent glioma in patients who are
symptomatic after high-dose radiotherapy. 18F-fluoro-2-deoxyglucose
positron emission tomography (FDG-PET), MR spectroscopy, and
perfusion imaging provide functional tissue information, and
may be able to differentiate the two entities, but the most useful
functional imaging modality has not been established yet (3,16).
Although the limited evidence indicates no substantial role for& Sons, Ltd. www.interscience.wiley.com/journal/nbm
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DWI (3), intravoxel diffusion heterogeneity imaging is based on
other biophysical principles (image contrast is different from
conventional DWI), and may be of value in distinguishing
radiation necrosis from recurrent glioma. The potential of
diffusion heterogeneity imaging in this field should be further
explored.
MR imaging is the standard imaging modality for brain tumor
evaluation, and DWI is one of the standard sequences in a brain
tumor protocol (1–3). Therefore, practical implementation of
intravoxel diffusion heterogeneity imaging is relatively easy, since
it only requires adding a few more b-values (> 1000 s/mm2) to a
conventional DWI sequence (which is usually performed using
b-values of 0 and 1000 s/mm2). Nevertheless, the present study is
limited by the fact only four b-values were acquired, as it was
designed to keep scan times reasonably short. Despite only four
diffusion weightings, non-uniform b-value sampling was chosen
to efficiently capture multi-exponential features at very high
b-values along with the traditional b-values of 0 and 1000 s/mm2.
Furthermore, the imaging requirements for diffusion heterogen-
eity imaging also introduce some limitations and drawbacks.
First, the use of SS-EPI (similar to conventional DWI) may lead to
image distortion and signal loss (17). Although these artifacts
have been considerably reduced thanks to the development of
high-performance gradients and parallel imaging (18), they may
still occur, especially at the base of the skull and the nasal sinuses,
and evaluation of tumors in these areas using diffusion
heterogeneity imaging may be hampered. In addition, the SNR
characteristics of diffusion heterogeneity imaging are rather poor
and voxel sizes tend to be large, which may hamper sensitivity to
tumor cells occupying a small fraction of a voxel. Another
disadvantage is that the use of high b-values (> 1000 s/mm2),
necessary to render MR imaging sensitive to multi-exponential
diffusion features, may impair the SNR on the amaps. The highest
b-value (4000 s/mm2) used in the present study was chosen
based on available SNR and diffusion properties of the tissues of
primary interest. High mobility environments, such as cere-
brospinal fluid and necrotic cysts, did not maintain adequate SNR
above background noise at high b-values ( 2000 s/mm2) thus
could not be reliably fit by the model. Low SNR voxels below a
noise threshold were tagged as ‘not-a-number’ and eliminated
from subsequent analysis (Fig. 2). Finally, fitting the stretch-
ed-exponential model to the DWI data to obtain whole-brain a
map takes extra post-processing time, and is typically not
included in clinical software packages.
A desirable feature of the stretched-exponential model is that it
involves only two parameters (DDC and a value) in the fitting
routine. The bi-exponential model has also been applied to fit to
multi-exponential tissue data, but this model requires three
parameters (two diffusion coefficients and the relative volume of
each diffusion pool). Assuming for a moment both models are
equally valid from a biophysical perspective, it is preferred to
utilize a two-parameter model over a three-parameter model in
fitting to so few data points. Other multi-exponential models
have been developed in an attempt to characterize non-
mono-exponential diffusion-weighted signal decay (19,20). For
example, Maier et al. (19) proposed quantifying the deviation of
the signal attenuation from mono-exponential decay by means
of the x2 value, and showed that x2 values of both peritumoral
edema and highly malignant tumors were significantly higher
than those of normal grey and white matter. Furthermore, Hall
and Barrick (20) suggested describing diffusion-weighted signal
decay in terms of the theory of anomalous diffusion, whichwww.interscience.wiley.com/journal/nbm Copyright  200assumes that the diffusion environment experienced by diffusing
spins is not locally homogeneous. The g value derived from this
anomalous diffusion model is comparable to the a value of the
stretched-exponential model. In addition, MR diffusion kurtosis
imaging was recently proposed to study the deviation of
water diffusion from Gaussian distribution. An advantage of this
method is that it only requires a modest increase in b-values
beyond those typically employed for DWI (21). Nevertheless,
although similarities exist among these models, acquired
parameters of non-mono-exponential diffusion-weighted signal
decay by each method should be interpreted differently,
since theoretical biophysical underpinnings of each model are
different.
A limitation of the present study is that a values of (apparently)
unaffected contralateral anatomic landmarks were measured
without the availability of histopathological correlation, and that
these areas cannot definitely be considered free of tumor cells
(12,13). Furthermore, only high-grade gliomas were investigated,
and it is still unclear whether there any significant differences
between normal brain tissue and low-grade gliomas or other
brain tumors. Despite these study limitations, the significantly
different a values between anatomic landmarks and high-grade
gliomas opens the path for several important potential clinical
applications of diffusion heterogeneity imaging, as described
previously.
In conclusion, the index a of human high-grade gliomas is
significantly different from those of normal brain structures,
which potentially offers a new method for evaluating brain
tumors. The observed negative correlation between tumor a and
tumor DDC requires further investigation.REFERENCES
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